0001556919-14-000002.txt : 20140318 0001556919-14-000002.hdr.sgml : 20140318 20140318114845 ACCESSION NUMBER: 0001556919-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140318 DATE AS OF CHANGE: 20140318 EFFECTIVENESS DATE: 20140318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TheraVasc Inc. CENTRAL INDEX KEY: 0001479295 IRS NUMBER: 270736716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-213791 FILM NUMBER: 14699942 BUSINESS ADDRESS: STREET 1: 10000 CEDAR AVENUE STREET 2: GCIC2-MS#1 CITY: CLEVELAND STATE: OH ZIP: 44106 BUSINESS PHONE: 318-349-3851 MAIL ADDRESS: STREET 1: 10000 CEDAR AVENUE STREET 2: GCIC2-MS#1 CITY: CLEVELAND STATE: OH ZIP: 44106 D 1 primary_doc.xml X0707 D LIVE 0001479295 TheraVasc Inc. 10000 CEDAR AVENUE GCIC2-MS#1 CLEVELAND OH OHIO 44106 318-349-3851 DELAWARE None None Corporation true 2009 Anthony Giordano 7515 Cedar Rd. Chesterland OH OHIO 44026 Executive Officer Director Kyle Chan 11575 Sorrento Valley Rd. Suite 210 San Diego CA CALIFORNIA 92121 Director John Zak Portal Ventures 2000 Auburn Drive, Suite 221 Beachwood OH OHIO 44122 Director Susan Luria 15900 S. Park Blvd. Shaker Heights OH OHIO 44120 Director John Huston 4282 Vaux Link New Albany OH OHIO 43054 Director Pharmaceuticals No Revenues 06b false 2014-03-10 false true true true false 0 2000000 350000 1650000 false 1 0 0 110000 true The CEO deferred salary for all of 2013. If at least $1.4M is raised, Dr. Giordano will receive the entire deferred compensation after the new R&D, licensing, and insurance expenses and accrued professional fees are first paid through 2014. false TheraVasc Inc. /s/ Anthony Giordano Anthony Giordano President and Chief Executive Officer 2014-03-11